Dr. Joseph on what to expect from proposed ABU Lifelong Learning Program changes
“There will always be changes. I'm entering my fourth cycle of recertification, and I can tell you that none of the 3 prior cycles were similar,” says David Joseph, MD.
In this video, David Joseph, MD, discusses proposed changes to the American Board of Urology’s Lifelong Learning Program as well as a potential timetable for when the changes will be implemented. Joseph is the Lifelong Learning Chair of the American Board of Urology. He is also a professor and vice-chair of academic affairs in the Department of Urology at the University of Alabama at Birmingham and the Beverly P. Head Endowed Chair in Pediatric Urology at Children’s of Alabama.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
